Forte Biosciences (FBRX) Debt to Equity (2016 - 2019)
Forte Biosciences (FBRX) reported Debt to Equity of -$8.67 for Q2 2019, down 1641.2% year-over-year from $0.56 in Q2 2018, and up 31.11% quarter-over-quarter from -$12.58 in Q1 2019.
Forte Biosciences (FBRX) Debt to Equity (2016 - 2019) Analysis & Trends
Forte Biosciences (FBRX) has 4 years of Debt to Equity data on file, last reported at -$8.67 in Q2 2019.
- Debt to Equity for Q2 2019 came in at -$8.67, down 1641.2% year-over-year; the trailing twelve-month figure through Jun 2019 was -$8.67 (down 1641.2% YoY), and the FY2018 annual result was -$35.6, down 69905.83% from the prior year.
- Debt to Equity grew to -$8.67 in Q2 2019 per FBRX's latest filing, from -$12.58 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.56 in Q2 2018 and troughed at -$35.6 in Q4 2018.
- A 4-year average of -$5.06 and a median of $0.03 in 2018 frame the typical range for Debt to Equity.
- On a YoY basis, Debt to Equity climbed as much as 730.04% in 2018 and fell as far as 69905.83% in 2018.
- A 4-year view of Debt to Equity shows it stood at -$0.08 in 2016, then jumped by 161.96% to $0.05 in 2017, then plunged by 69905.83% to -$35.6 in 2018, then jumped by 75.66% to -$8.67 in 2019.
- Business Quant data shows FBRX's Debt to Equity at -$8.67 in Q2 2019, -$12.58 in Q1 2019, and -$35.6 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -8.67 |
| Mar 31, 2019 | -12.58 |
| Dec 31, 2018 | -35.60 |
| Sep 30, 2018 | 0.55 |
| Jun 30, 2018 | 0.56 |
| Mar 31, 2018 | 0.03 |
| Dec 31, 2017 | 0.05 |
| Sep 30, 2017 | 0.07 |
| Jun 30, 2017 | 0.08 |
| Mar 31, 2017 | -0.06 |
| Dec 31, 2016 | -0.08 |